We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Rockwell Automation
ROK
$47.7B
| $1.26M | 0.03% |
12,405
-310
| -2% | -$35.1K |
2013 Q2
9 quarters
|
|
252
Insulet
PODD
$9.82B
| $1.23M | 0.02% |
47,282
-3,904
| -8% | -$118K |
2013 Q2
9 quarters
|
|
253
Everforth Inc
EFOR
$1.55B
| $1.21M | 0.02% |
32,908
+13,167
| +67% | +$500K |
2013 Q2
9 quarters
|
|
|
CARB
254
DELISTED
Carbonite Inc
CARB
| $1.19M | 0.02% |
107,163
+38,820
| +57% | +$446K |
2015 Q2
1 quarter
|
|
255
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $1.17M | 0.02% |
15,061
| – | – |
2013 Q2
9 quarters
|
|
|
MHNB.CL
256
DELISTED
Maiden Holdings North America
MHNB.CL
| $1.13M | 0.02% |
42,800
+700
| +2% | +$18.6K |
2013 Q2
9 quarters
|
|
257
Trex
TREX
$4.66B
| $1.13M | 0.02% |
134,964
+50,888
| +61% | +$523K |
2013 Q2
9 quarters
|
|
258
Jefferies Financial Group
JEF
$10.3B
| $1.12M | 0.02% |
61,900
-36
| -0.1% | -$723 |
2013 Q2
9 quarters
|
|
|
ELLI
259
DELISTED
Ellie Mae Inc
ELLI
| $1.11M | 0.02% |
+16,647
| New | +$1.23M |
2015 Q3
0 quarters
|
|
260
Colgate-Palmolive
CL
$74.3B
| $1.1M | 0.02% |
17,290
-28
| -0.2% | -$1.83K |
2013 Q2
9 quarters
|
|
261
WisdomTree
WT
$3.21B
| $1.09M | 0.02% |
67,632
+24,645
| +57% | +$519K |
2015 Q1
2 quarters
|
|
262
Diamondback Energy
FANG
$56.8B
| $1.08M | 0.02% |
16,660
+4,690
| +39% | +$319K |
2014 Q4
3 quarters
|
|
263
Sabre
SABR
$686M
| $1.05M | 0.02% |
38,691
-704
| -2% | -$19K |
2015 Q1
2 quarters
|
|
264
Norfolk Southern
NSC
$72.9B
| $1.04M | 0.02% |
13,651
+9
| +0.1% | +$731 |
2013 Q2
9 quarters
|
|
265
UnitedHealth
UNH
$360B
| $1.04M | 0.02% |
8,980
+138
| +2% | +$16.5K |
2013 Q2
9 quarters
|
|
266
Amgen
AMGN
$234B
| $1.04M | 0.02% |
7,511
+608
| +9% | +$95.8K |
2013 Q2
9 quarters
|
|
267
Oxford Square Capital
OXSQ
$141M
| $1.04M | 0.02% |
154,723
| – | – |
2013 Q3
8 quarters
|
|
|
KMPA
268
DELISTED
Kemper Corporation
KMPA
| $1.04M | 0.02% |
39,300
+600
| +2% | +$15.9K |
2014 Q1
6 quarters
|
|
269
DELISTED
Leggett & Platt
LEG
| $1.03M | 0.02% |
25,051
+1,170
| +5% | +$54.6K |
2014 Q2
5 quarters
|
|
270
US Bancorp
USB
$91.2B
| $1.02M | 0.02% |
24,964
-3,738
| -13% | -$162K |
2013 Q2
9 quarters
|
|
271
Bank of America
BAC
$360B
| $1.02M | 0.02% |
65,491
+19,795
| +43% | +$333K |
2013 Q2
9 quarters
|
|
272
Lazard
LAZ
$3.52B
| $1.01M | 0.02% |
23,230
| – | – |
2013 Q2
9 quarters
|
|
|
SBY
273
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $990K | 0.02% |
61,817
-9,999
| -14% | -$163K |
2013 Q2
9 quarters
|
|
|
VNRBP
274
DELISTED
Vanguard Natural Resources LLC 7.625% Series B Cumulative Redeemable Perpetual Preferred Unit
VNRBP
| $931K | 0.02% |
61,190
+550
| +0.9% | +$10.2K |
2014 Q1
6 quarters
|
|
275
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $926K | 0.02% |
7,887
-6,940
| -47% | -$859K |
2013 Q3
8 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.